A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.
about
Genital Herpes: Insights into Sexually Transmitted Infectious DiseasePeptide therapeutics for treating ocular surface infectionsAn investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.A Mouse Model of Multi-Drug Resistant Staphylococcus aureus-induced Ocular DiseaseInhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.Cell entry mechanisms of HSV: what we have learned in recent years.
P2860
Q30235026-FBC34DC6-7F21-4F75-A7FC-EEE4D8C2D8DFQ34454864-DFF6810A-5C30-40C6-853D-E8D6F5862F8FQ37208892-A894F775-CD6A-49CE-B154-F90FAE125EB0Q37441216-9246BB54-C9A6-497E-A068-6101CA41FFA6Q37551831-E015DC63-4149-4C5B-AA2A-D74D0CE45688Q37590904-468A8468-ED2E-4FEC-9537-77B0C52B7011Q38882932-C54749F0-A4BB-429E-A2A4-D43FE119650E
P2860
A cationic peptide, TAT-Cd°, inhibits herpes simplex virus type 1 ocular infection in vivo.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@ast
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@en
type
label
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@ast
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@en
prefLabel
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@ast
A cationic peptide, TAT-Cd°, i ...... pe 1 ocular infection in vivo.
@en
P2093
P2860
P356
P1476
A cationic peptide, TAT-Cd°, i ...... ype 1 ocular infection in vivo
@en
P2093
Curtis R Brandt
Erica Carballo
Gilbert G Jose
Inna V Larsen
Rachel Brummel
Rebecca Stern
P2860
P304
P356
10.1167/IOVS.12-10250
P407
P577
2013-02-05T00:00:00Z